Crossmark

Dosing interval optimization and persistence with faricimab in age-related macular degeneration: An observational study in real-world clinical practice

Crossref DOI link: https://doi.org/10.1016/j.farma.2025.12.002

Published Print: 2026-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cornejo-Uixeda, Silvia

Borrás-Blasco, Joaquín

Valcuende-Rosique, Alejandro

Gil, Leonor Perez

Monteagudo-Martinez, Nuria

Merino, Virginia
License Information

Text and Data Mining valid from 2026-07-01

Text and Data Mining valid from 2026-07-01

Version of Record valid from 2025-12-09
More Information

This article is maintained by: Elsevier

Article Title: Dosing interval optimization and persistence with faricimab in age-related macular degeneration: An observational study in real-world clinical practice

Journal Title: Farmacia Hospitalaria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2025.12.002

Content Type: article

Copyright: © 2025 Sociedad Española de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below